Difference between revisions of "LncRNAWiki:Endocrine System Diseases"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Disease !width="50"|LncRNAs |- |diabetes |''CDKN2B-AS1'', ''MALAT1'', ''MEG3'', ''LINC00673'', ...") |
|||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] | ||
+ | </div> | ||
+ | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
+ | !width="50"|Name | ||
+ | !width="50"|Transcript ID | ||
+ | !width="50"|Alias | ||
+ | !width="50"|Description | ||
!width="50"|Disease | !width="50"|Disease | ||
− | + | ||
|- | |- | ||
− | + | |''PVT1'' | |
− | |'' | + | |[[ENST00000513868.2]] |
+ | |"NCRNA00079, LINC00079, onco-lncRNA-100" | ||
+ | |Pvt1 oncogene (non-protein coding) | ||
+ | |breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer | ||
|- | |- | ||
+ | |''MALAT1'' | ||
+ | |[[ENST00000534336.1]] | ||
+ | |"HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562" | ||
+ | |metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | ||
+ | |B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer | ||
+ | |- | ||
+ | |''MEG3'' | ||
+ | |[[NONHSAT039745]] | ||
+ | |"Gtl2, ENSG00000214548" | ||
+ | |maternally expressed 3 (non-protein coding) | ||
+ | |bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes | ||
+ | |- | ||
+ | |''XIST'' | ||
+ | |[[NONHSAT137541]] | ||
+ | |ENSG00000229807 | ||
+ | |X inactive-specific transcript | ||
+ | |bladder cancer, breast cancer, Klinefelter's syndrome, testicular cancer | ||
+ | |- | ||
+ | |''CDKN2B-AS1'' | ||
+ | |[[NONHSAT130421]], | ||
+ | [[lnc-C9orf53-2:1]] | ||
+ | |"ANRIL, p15AS, ENSG00000240498" | ||
+ | |CDKN2B antisense RNA 1 | ||
+ | |abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer, | ||
+ | |- | ||
+ | |''DGCR10'' | ||
+ | |[[DGCR10]] | ||
+ | |DGS-B | ||
+ | |DiGeorge syndrome critical region gene 10 (non-protein coding) | ||
+ | |DiGeorge syndrome | ||
+ | |- | ||
+ | |''DGCR11'' | ||
+ | |[[DGCR11]] | ||
+ | |DGS-D | ||
+ | |DiGeorge syndrome critical region gene 11 (non-protein coding) | ||
+ | |DiGeorge and velo-cardio-facial syndrome | ||
+ | |- | ||
+ | |''DGCR12'' | ||
+ | |[[DGCR12]] | ||
+ | |DGS-E | ||
+ | |DiGeorge syndrome critical region gene 12 (non-protein coding) | ||
+ | |DiGeorge and velo-cardio-facial syndrome | ||
+ | |- | ||
+ | |''DGCR5'' | ||
+ | |[[DGCR5]] | ||
+ | |"NCRNA00037, LINC00037" | ||
+ | |DiGeorge syndrome critical region gene 5 (non-protein coding) | ||
+ | |DiGeorge syndrome | ||
+ | |- | ||
+ | |''DGCR9'' | ||
+ | |[[DGCR9]] | ||
+ | |"DGS-A, POM121L5P" | ||
+ | |DiGeorge syndrome critical region gene 9 (non-protein coding) | ||
|DiGeorge syndrome | |DiGeorge syndrome | ||
− | |||
|- | |- | ||
− | | | + | |''IGF2-AS'' |
− | |'' | + | |[[IGF2-AS]] |
− | | | + | |"PEG8, IGF2-AS1" |
+ | |IGF2 antisense RNA | ||
+ | |hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor | ||
+ | |- | ||
+ | |''LINC00673'' | ||
+ | |[[LINC00673]] | ||
+ | |HI-LNC75 | ||
+ | |long intergenic non-protein coding RNA 673 | ||
+ | |type 2 diabetes | ||
+ | |- | ||
+ | |''LINC01512'' | ||
+ | |[[LINC01512]] | ||
+ | |"LOC100132354, TCONSN/A00011120, HI-LNC77" | ||
+ | |long intergenic non-protein coding RNA 1512 | ||
+ | |type 2 diabetes | ||
+ | |- | ||
+ | |''LINC01574'' | ||
+ | |[[LINC01574]] | ||
+ | |"HI-LNC12, TCONSN/A00009551" | ||
+ | |long intergenic non-protein coding RNA 1574 | ||
+ | |type 2 diabetes | ||
+ | |- | ||
+ | |''TUNAR'' | ||
+ | |[[TUNAR]] | ||
+ | |"TUNA, HI-LNC78" | ||
+ | |TCL1 upstream neural differentiation-associated RNA | ||
+ | |type 2 diabetes | ||
+ | |- | ||
+ | |''FLICR'' | ||
+ | |[[FLICR]] | ||
+ | |N/A | ||
+ | |FOXP3 regulating long intergenic non-coding RNA | ||
+ | |Autoimmune diabetes | ||
+ | |- | ||
+ | |''LINC02402'' | ||
+ | |[[LINC02402]] | ||
+ | |ENST00000550337.1 | ||
+ | |long intergenic non-protein coding RNA 2402 | ||
+ | |Pre-Diabetes, Type 2 Diabetes Mellitus | ||
+ | |- | ||
+ | |''PLUT'' | ||
+ | |[[PLUT]] | ||
+ | |PDX1-AS1, PLUTO, HI-LNC71 | ||
+ | |PDX1 associated lncRNA, upregulator of transcription | ||
+ | |Type 2 diabetes | ||
+ | |- |
Revision as of 03:45, 30 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
PVT1 | ENST00000513868.2 | "NCRNA00079, LINC00079, onco-lncRNA-100" | Pvt1 oncogene (non-protein coding) | breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer |
MALAT1 | ENST00000534336.1 | "HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562" | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer |
MEG3 | NONHSAT039745 | "Gtl2, ENSG00000214548" | maternally expressed 3 (non-protein coding) | bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes |
XIST | NONHSAT137541 | ENSG00000229807 | X inactive-specific transcript | bladder cancer, breast cancer, Klinefelter's syndrome, testicular cancer |
CDKN2B-AS1 | NONHSAT130421, | "ANRIL, p15AS, ENSG00000240498" | CDKN2B antisense RNA 1 | abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer, |
DGCR10 | DGCR10 | DGS-B | DiGeorge syndrome critical region gene 10 (non-protein coding) | DiGeorge syndrome |
DGCR11 | DGCR11 | DGS-D | DiGeorge syndrome critical region gene 11 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR12 | DGCR12 | DGS-E | DiGeorge syndrome critical region gene 12 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR5 | DGCR5 | "NCRNA00037, LINC00037" | DiGeorge syndrome critical region gene 5 (non-protein coding) | DiGeorge syndrome |
DGCR9 | DGCR9 | "DGS-A, POM121L5P" | DiGeorge syndrome critical region gene 9 (non-protein coding) | DiGeorge syndrome |
IGF2-AS | IGF2-AS | "PEG8, IGF2-AS1" | IGF2 antisense RNA | hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor |
LINC00673 | LINC00673 | HI-LNC75 | long intergenic non-protein coding RNA 673 | type 2 diabetes |
LINC01512 | LINC01512 | "LOC100132354, TCONSN/A00011120, HI-LNC77" | long intergenic non-protein coding RNA 1512 | type 2 diabetes |
LINC01574 | LINC01574 | "HI-LNC12, TCONSN/A00009551" | long intergenic non-protein coding RNA 1574 | type 2 diabetes |
TUNAR | TUNAR | "TUNA, HI-LNC78" | TCL1 upstream neural differentiation-associated RNA | type 2 diabetes |
FLICR | FLICR | N/A | FOXP3 regulating long intergenic non-coding RNA | Autoimmune diabetes |
LINC02402 | LINC02402 | ENST00000550337.1 | long intergenic non-protein coding RNA 2402 | Pre-Diabetes, Type 2 Diabetes Mellitus |
PLUT | PLUT | PDX1-AS1, PLUTO, HI-LNC71 | PDX1 associated lncRNA, upregulator of transcription | Type 2 diabetes |